Pre-Implantation Methylation Screening(PIMS)
Product introduction
Pre-Implantation Methylation Screening (PIMS) can examine both the copy number variation of chromosomes (CNV) and DNA methylation information with a self-developed single-cell genome methylation sequencing method, combined with artificial intelligence algorithm to screen the embryo developmental potential, select embryo for implantation, and thus promote the birth rates.
Product advantage
innovative technology
new scientific discovery——the relationship with methylation and embryonic development
epigenetic testing——embryonic imprinted gene detection
three detection
genome methylation detection
copy number variation of chromosomes (CNV) detection
epigenetic diseases detection
clinical improvement
promote the birth rates
reduce the birth defect rates
accurate detection
high resolution——the detection accuracy can reach 1Mb
high coverage——cover all chromosomes
Applicable population
all IVF family
patients with recurrent spontaneous abortion
patients with repeated implantation failure
Service process
genetic counseling
identify the clinical indications
sample collection
6-8 trophoblast cell
sample transport
cold chain transport at -80°C
full range temperature monitoring
PIMS detection
15 workdays
detection report
ranking of embryo for implantation
